The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Ras gene mutation and amplification in human nonmelanoma skin cancers
Abstract
Our previous studies have shown that human skin cancers occurring on sun‐exposed body sites frequently contain activated Ha‐ras oncogenes capable of inducing morphologic and tumorigenic transformation of NIH 3T3 cells. In this study, we analyzed human primary squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) occurring on sun‐exposed body sites for mutations in codons 12, 13, and 61 of Ha‐ras, Ki‐ras, and N‐ras oncogenes by amplification of genomic tumor DNAs by the polymerase chain reaction, followed by dot‐blot hybridization to synthetic oligonucleotide probes designed to detect single base‐pair mutations. In addition to the primary human skin cancers, we also analyzed Ha‐ras‐positive NIH 3T3 transformants for mutations in the Ha‐ras oncogene. The results indicated that all three NIH 3T3 transformants, 11 of 24 (46%) SCCs, and 5 of 16 (31 %) BCCs contained mutations at the second position of Ha‐ras codon 12 (GGC→GTC), predicting a glycine‐to‐valine amino acid substitution, whereas only 1 of 40 skin cancers (an SCC) displayed a mutation in the first position of Ki‐ras codon 12 (GGT→AGT), predicting a glycine‐to‐serine amino acid change. In addition, three of the SCCs contained highly amplified copies of the N‐ras oncogene in their genomic DNA. Interestingly, two of the SCCs containing amplified N‐ras sequences also had G→T mutations in codon 12 of the Ha‐ras oncogene. These studies demonstrate that mutations in codon 12 of the Ha‐ras oncogene occurred at a high frequency in human skin cancers originating on sun‐exposed body sites, whereas mutation in codon 12 of Ki‐ras or amplification of N‐ras occurred at a low frequency. Since the mutations in the Ha‐ras and Ki‐ras oncogenes were located opposite potential pyrimidine dimer sites (C‐C), it is likely that these mutations were induced by ultraviolet radiation present in sunlight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
CELLULAR ONCOGENES AND RETROVIRUSES
Bishop, J. M. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001505 · Cited by 1,641
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
TECHNOLOGICAL EXAMINATION OF LOW‐FIRED TERRACOTTA STATUES FROM AYIA IRINI, KEA
MANIATIS, Y., KATSANOS, A., & CASKEY, M. E. (1982) · Archaeometry · doi:10.1111/j.1475-4754.1982.tb01001.x · Cited by 1,258
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor
Wigler, M., Pellicer, A., Silverstein, S., & Axel, R. (1978) · Cell · doi:10.1016/0092-8674(78)90254-4 · Cited by 1,210
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,127
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., & Perucho, M. (1987) · Nature · doi:10.1038/327298a0 · Cited by 1,061
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859
Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., & Barbacid, M. (1985) · Nature · doi:10.1038/315382a0 · Cited by 820
The ras gene family and human carcinogenesis
Bos, J. L. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90004-8 · Cited by 782
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas
Smit, V. T. H. B. M., Boot, A. J. M., Smits, A. M. M., Fleuren, G. J., Cornelisse, C. J., & Bos, J. L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.16.7773 · Cited by 626
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides
Verlaan-de Vries, M., Bogaard, M. E., van den Elst, H., van Boom, J. H., van der Eb, A. J., & Bos, J. L. (1986) · Gene · doi:10.1016/0378-1119(86)90335-5 · Cited by 336
High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas
Grünewald, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. G., & Bartram, C. R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430614 · Cited by 290
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
van 't Veer, L. J., Burgering, B. M., Versteeg, R., Boot, A. J., Ruiter, D. J., Osanto, S., Schrier, P. I., & Bos, J. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3114 · Cited by 283
Brown, K., Buchmann, A., & Balmain, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.538 · Cited by 272
Activation of ras Oncogenes Preceding the Onset of Neoplasia
Kumar, R., Sukumar, S., & Barbacid, M. (1990) · Science · doi:10.1126/science.2188364 · Cited by 258
Lippke, J. A., Gordon, L. K., Brash, D. E., & Haseltine, W. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3388 · Cited by 250
Rosenstein, B. S., & Mitchell, D. L. (1987) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1987.tb07881.x · Cited by 188
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours
Fujita, J., Yoshida, O., Yuasa, Y., Rhim, J. S., Hatanaka, M., & Aaronson, S. A. (1984) · Nature · doi:10.1038/309464a0 · Cited by 183
Ras Oncogene Mutations in Basal Cell Carcinomas and Squamous Cell Carcinomas of Human Skin
van der Schroeff, J. G., Evers, L. M., Boot, A. J. M., & Bos, J. L. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874504 · Cited by 179
Activation of N-ras in a Human Melanoma Cell Line
Padua, R. A., Barrass, N. C., & Currie, G. A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.582-585.1985 · Cited by 92
Preferential and novel activation of H-ras in human bladder carcinomas.
Kv, V., Pocock, R., & Summerhayes, I. C. (1988) · PubMed · Cited by 75
Shukla, V. K., Hughes, D. C., Hughes, L. E., McCormick, F. P., & Padua, R. A. (1989) · PubMed · Cited by 70
Ananthaswamy, H. N., Price, J. E., Goldberg, L. H., & Bales, E. S. (1988) · PubMed · Cited by 63
Self-citationActivated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez, H. G., Daya–Grosjean, L., Schlaifer, D., Nardeux, P., Renault, G., Bos, J. L., & Sarasin, A. R. (1989) · PubMed · Cited by 54
Skin cancer epidemiology: research needs.
Scotto, J., & Fears, T. R. (1978) · PubMed · Cited by 39
Malone, P. R., Visvanathan, K., Ponder, B. A. J., Shearer, R. J., & Summerhayes, I. C. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb07028.x · Cited by 36
Keijzer, W., Mulder, M. P., Langeveld, J. C. M., Smit, E. M. E., Bos, J. L., Bootsma, D., & Hoeijmakers, J. H. J. (1989) · PubMed · Cited by 32
Ananthaswamy, H. N., Price, J. E., Goldberg, L. H., & Bales, E. S. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360205 · Cited by 19
Self-citation
Cited by
Maubec, E., Petrow, P., Scheer-Senyarich, I., Duvillard, P., Lacroix, L., Gelly, J., Certain, A., Duval, X., Crickx, B., Buffard, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.1735 · Cited by 470
Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
Nilsson, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050467397 · Cited by 436
Somatic mutations in the PTCH,SMOH,SUFUH and TP53 genes in sporadic basal cell carcinomas
Reifenberger, J., Wolter, M., Knobbe, C. B., Köhler, B., Schönicke, A., Scharwächter, C., Kumar, K., Blaschke, B., Ruzicka, T., & Reifenberger, G. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06353.x · Cited by 399
Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification
Röwert-Huber, J., Patel, M. J., Forschner, T., Ulrich, C., Eberle, J., Kerl, H., Sterry, W., & Stockfleth, E. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07860.x · Cited by 380
Cellular and molecular events leading to the development of skin cancer
Melnikova, V. O., & Ananthaswamy, H. N. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.11.015 · Cited by 376
Self-citation
Metadata
- Authors
- Pierceall, W. E., Goldberg, L. H., Tainsky, M. A., Mukhopadhyay, T., & Ananthaswamy, H. N.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 1991-01
- Volume
- 4
- Issue
- 3
- Pages
- 196-202
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2062210994
- Cited by
- 278
- References
- 35
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.